Research progress on radiotherapy combined with immunotherapy for non-small cell lung cancer
10.3760/cma.j.cn113030-20211014-00405
- VernacularTitle:非小细胞肺癌胸部放疗联合免疫治疗研究进展
- Author:
Tongzhen XU
1
;
Jun LIANG
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科，北京 100021
- Keywords:
Carcinoma, non-small-cell lung;
Radiotherapy;
Immunotherapy;
Research progress
- From:
Chinese Journal of Radiation Oncology
2022;31(6):579-584
- CountryChina
- Language:Chinese
-
Abstract:
Radiotherapy combined with immunotherapy for non-small cell lung cancer (NSCLC), especially with PD-1/PD-L1 immune checkpoint inhibitors, have fallen under the spotlight in recent years. How to explore the optimal combination modality of radiotherapy and immunotherapy to maximize the benefits for all-stage patients is one of the developing directions of clinical research. This article expounds the effect of radiotherapy on tumor immunology, research progress on radiotherapy combined with immunotherapy for various stages of NSCLC, and the problems existing in radiotherapy combined with immunotherapy.
